title: Hemolysis during long-term extracorporeal membrane oxygenation.
abstract: We studied the cause of hemolysis during extracorporeal membrane oxygenation (ECMO) by monitoring hematologic and coagulation profiles in seven consecutive infants treated with this procedure. A constrained vortex pump was used in all patients, and the average duration of ECMO was 224 +/- 111 (SD) hours. In all patients, plasma free hemoglobin was low during the first 48 hours after the initiation of ECMO. Later, when visible clots appeared in the ECMO circuit, plasma hemoglobin progressively rose. A rise in the level of fibrin degradation products and a fall in the fibrinogen level were observed concurrently with a rise in the plasma hemoglobin level. After complete circuit changes in six patients, plasma free hemoglobin, fibrin split products, and fibrinogen all returned to baseline values. Neither circuit component changes nor exchange transfusion was effective in normalizing the levels of plasma free hemoglobin, fibrin split products, and fibrinogen. We conclude that when ECMO is administered for prolonged periods, circuit thrombosis occurs and hemolysis ensues. Additional studies are needed to assess the contribution of the constrained vortex pump to this process.
authors: Department of Pediatrics, University of Minnesota, Minneapolis.
authors: R H
authors: RH
authors: Steinhorn
authors: B
authors: B
authors: Isham-Schopf
authors: C
authors: C
authors: Smith
authors: T P
authors: TP
authors: Green
mesh_terms: D005078:Exchange Transfusion, Whole Blood; D015199:Extracorporeal Membrane Oxygenation / Q000009:adverse effects*; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D005340:Fibrinogen / Q000032:analysis; D006454:Hemoglobins / Q000032:analysis; D006461:Hemolysis; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn
chemical_list: D005338:Fibrin Fibrinogen Degradation Products; D006454:Hemoglobins; D005340:Fibrinogen; D006493:Heparin